United States · FDA National Drug Code directory
Croton Tiglium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 37662-0517_e15c8fc4-f44c-5922-e053-2995a90a6e41
- Product NDC
- 37662-0517
- Form
- PELLET
- Composition / generic term
- Croton Tiglium
- Labeler
- Hahnemann Laboratories, INC.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20220613
- Source listing expiry
- 20261231
Source-listed ingredients
- CROTON TIGLIUM SEED — 200 [hp_C]/1
These values do not establish equivalence or a dose recommendation.
Packages
- 200 PELLET in 1 VIAL, GLASS (37662-0517-1) · 37662-0517-1
- 500 PELLET in 1 VIAL, GLASS (37662-0517-2) · 37662-0517-2
- 3000 PELLET in 1 BOTTLE, GLASS (37662-0517-3) · 37662-0517-3
- 10000 PELLET in 1 BOTTLE, GLASS (37662-0517-4) · 37662-0517-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →